Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06120764 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 1, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 30, 2025 to Sep 30, 2026
    • Study completion date: Dec 30, 2025 to Oct 30, 2026
    v5
  2. Primary completion date: Jun 30, 2025 to Dec 30, 2025
    • Study completion date: Jul 30, 2025 to Dec 30, 2025
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Primary completion date: Nov 30, 2024 to Jun 30, 2025v2 Show 7 more changesShow less
    • Enrollment target: 30 to 40
    • Study completion date: Mar 30, 2025 to Jul 30, 2025
    • Start date changed from estimate of Nov 5, 2023 to Nov 10, 2023
    • Secondary endpoints: details revised at 4 of 5 entries
    • Site details revised
    • Eligibility criteria shortened, about 5 words
    • Study description expanded, about 2 words
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients. Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.
Trial Details
NCT Number NCT06120764
Lead Sponsor Baskent University
Collaborators: Hacettepe University
Conditions
(from sponsor)		 Chemotherapy-induced Nausea and Vomiting, Pediatric Cancer
Related terms Neoplasms, Vomiting
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov